Dermatology · New Haven, CT
NPI
1457527442
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
20 York St, T-209
New Haven, CT, 06510
Phone (203) 688-2259
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,945 services
Medicare patients, 2024
595
Average age 75
Drug cost, 2024
$2.6M
1,606 prescriptions
Company payments, 2025
$242K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher G Bunick was code 17003 (destruction skin lesion), 582 times for 122 patients. In total Christopher G Bunick billed 1,945 services in 41 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 582 | 122 | $5.40 | $3,141 |
| 99213 Office E&M - Established | Office | 529 | 444 | $65.75 | $35K |
| 17000 Destruction Skin Lesion | Office | 198 | 169 | $44.08 | $8,728 |
| 17110 Destruction Skin Lesion | Office | 129 | 122 | $88.57 | $11K |
| 11102 Skin Biopsy | Office | 121 | 108 | $74.64 | $9,031 |
| 99203 Office E&M - New | Office | 68 | 68 | $83.24 | $5,660 |
| 12032 Wound Repair - All Levels | Office | 42 | 38 | $230.09 | $9,664 |
| 99214 Office E&M - Established | Office | 34 | 32 | $91.19 | $3,100 |
| 99212 Office E&M - Established | Office | 33 | 32 | $45.28 | $1,494 |
| 11103 Skin Biopsy | Office | 25 | 18 | $42.42 | $1,061 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 24 | 12 | $0.51 | $12.21 |
| 11603 Skin Lesion Excision | Office | 24 | 22 | $117.47 | $2,819 |
| 11602 Skin Lesion Excision | Office | 19 | 16 | $102.96 | $1,956 |
| 17004 Destruction Skin Lesion | Office | 14 | 13 | $112.29 | $1,572 |
| 11900 Skin | Office | 12 | 12 | $41.67 | $500 |
By year: 2022 $105K for 2,013 services; 2023 $111K for 2,002 services; 2024 $104K for 1,945 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher G Bunick prescribed most often to Medicare patients was Clobetasol Propionate, with 212 prescriptions and refills. In total Christopher G Bunick wrote 1,606 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 212 | 240 | 140 | $8,275 |
| Triamcinolone Acetonide Generic | 193 | 206 | 140 | $2,297 |
| Ketoconazole Generic | 141 | 160 | 64 | $1,857 |
| Dupixent Pen Dupilumab | 105 | 105 | 11 | $356K |
| Dupixent Syringe Dupilumab | 68 | 75 | Under 11 | $289K |
| Doxycycline Hyclate Generic | 60 | 112 | 35 | $3,553 |
| Metronidazole Generic | 43 | 57 | 26 | $1,880 |
| Minoxidil Generic | 42 | 123 | 17 | $614 |
| Skyrizi Pen Risankizumab-Rzaa | 41 | 115 | 12 | $806K |
| Tretinoin Generic | 35 | 50 | 15 | $2,347 |
| Ciclopirox Generic | 32 | 34 | 13 | $637 |
| Mupirocin Generic | 32 | 32 | 19 | $177 |
| Spironolactone Generic | 31 | 78 | 12 | $233 |
| Ciclopirox Ciclopirox Olamine | 30 | 39 | 14 | $346 |
| Tacrolimus Generic | 24 | 31 | 11 | $2,348 |
Brand drugs: 435 claims; generic drugs: 1,171 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher G Bunick $242K ($239K in general payments such as food, travel and fees and $3,200 for research) from 22 companies. The largest payer was LEO Pharma Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 53 | $41K |
| Pfizer Inc. PFE | 31 | $37K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $33K |
| Novartis Pharmaceuticals Corporation NVS | 16 | $26K |
| UCB, Inc. UCB.BR | 43 | $20K |
| Abbvie Inc. ABBV | 23 | $16K |
| Genzyme Corporation SNY | 17 | $13K |
| Incyte Corporation INCY | 11 | $13K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 10 | $12K |
| Eli Lilly and Company LLY | 7 | $11K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.